XML 40 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Compensatory Equity Incentive Plan and Other Equity Incentives (Tables)
 6 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of share based compensation award plans

These plans are summarized below:

 

   Award Shares   Award Shares Outstanding
at December 31,		   Available for
Issuance
at December 31,		 
Equity Compensation Arrangement  Authorized   2017   2017 
Omnibus Plan   5,115,625    2,724,388    1,664,870 
2014 ESPP   400,000    —    370,895 
    5,515,625    2,724,388    2,035,765 

 
Schedule of stock options fair value assumptions

For stock options granted under the Omnibus Plan in the six month periods ended December 31, 2017 and 2016, we estimated the fair value of each stock option as of the date of grant using the following assumptions:

 

  Six months ended December 31,
  2017 2016
Weighted average expected volatility 63% - 75% 80% - 82%
Dividend yields 0% 0%
Weighted average risk-free interest rate 1.28% - 1.80% 1.185% - 1.19%
Weighted average expected term, in years 7.25 7.49

 
Schedule of share-based payment awards activity

A summary of the activity for share-based compensation awards under the Omnibus Plan in the six months ended December 31, 2017 is presented below:

 

     Stock Options     Restricted
Stock Units (RSUs)		 
     Shares     Weighted-
Average
Exercise
Price 		    Weighted-
Average
Remaining
Contract 		     Shares     Weighted-
Average
Remaining
Contract 		 
June 30, 2017   1,096,186   $1.68    6.3    1,508,782    0.9 
                          
Granted   48,849   $4.24    —    140,571    — 
Exercised   (46,250)  $2.24    —    —    — 
Cancelled/Forfeited   (23,750)  $3.10    —    —    — 
December 31, 2017   1,075,035   $1.74    6.4    1,649,353    0.9 
                          
Awards exercisable/vested as of                         
December 31, 2017   860,491   $1.62    5.8    1,287,370    — 
                          
Awards unexercisable/unvested as of                         
December 31, 2017   214,544   $2.22    8.7    361,983    0.9 
    1,075,035              1,649,353      

 
Schedule of share-based compensation future cost to be recognized

We expect to recognize the compensation cost as follows:

 

 

   Stock         
   Options   RSUs   Total 
Six months ending June 30, 2018   29,982    249,946    279,928 
                
Year ending June 30, 2019   18,083    264,982    283,065 
                
Year ending June 30, 2020   4,276    149,944    154,220 
                
Year ending June 30, 2021   2,105    29,978    32,083 
   $54,446   $694,850   $749,296 

 
Summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards

The following table is a summary of the number and weighted average grant date fair values regarding our unexercisable/unvested awards as of December 31, 2017 and changes during the six months then ended:

 

Unexercisable/unvested awards  Stock
Options
Shares		   RSU Shares   Total
Shares		   Weighted-Average
Grant Date Fair Values
(per share)		 
June 30, 2017   244,511    438,912    683,423   $1.39 
Granted   48,849    140,571    189,420   $3.69 
Vested   (75,066)   (217,500)   (292,566)  $1.40 
Cancelled/Forfeited   (3,750)   —    (3,750)  $1.39 
December 31, 2017   214,544    361,983    576,527   $1.52 

 
Schedule of total stock-based compensation expense included in the consolidated statements of comprehensive income

The following table shows total stock-based compensation expense for the six months ended December 31, 2017 and 2016 included in the consolidated statements of comprehensive income:

 

   Six Months Ended December 31, 
   2017   2016 
         
Stock options  $164,929   $22,804 
RSUs   21,280    188,197 
     Total  $186,209   $211,001 
           
The amounts above were included in:          
Selling, general & administrative  $182,277   $209,609 
Cost of sales   3,206    796 
New product development   726    596 
   $186,209   $211,001